Princeton, NJ - According to Tien Nguyen of Princeton University, "Researchers at Princeton have developed a new chemical reaction that breaks the strongest bond in a molecule instead of the weakest, completely reversing the norm for reactions in which bonds are evenly split to form reactive intermediates."
Princeton, NJ - According to Tien Nguyen of Princeton University, "Researchers at Princeton have developed a new catalyst that may give unprecedented access to cyclobutanes, four-membered ring-containing molecules that have been relatively unexplored. Held back by the limited scope of previous methods, called [2π+2π] reactions, many cyclobutanes compounds have been out of reach, along with any unique properties that may be of interest to the pharmaceutical or fine chemical industry."
Trenton, NJ - According to Melissa Orsen of the NJEDA, "
Trenton, NJ - According to Hal Bozarth of the Chemistry Council of NJ, “I have been fortunate enough to be involved with the business of chemistry for nearly 30 years,” says Shawn Blythe, chairman of the Chemistry Council of New Jersey. “My work has involved several US states as well as more than a dozen countries, and it’s with that global perspective that I firmly believe the state is uniquely positioned.”
Princeton, NJ - According to Brenda Mikeo of Princeton Research, "José Avalos is an assistant professor of chemical and biological engineering, jointly appointed with the Andlinger Center for Energy and the Environment. His interests lie in the use of biotechnology to address important issues in sustainable energy, the environment, industry, and human health. Avalos’ research focuses specifically on synthetic biology and metabolic engineering for the production of biofuels and bio-derived chemicals."
Montclair, NJ. –David Rotella, the Montclair State University Sokol Professor of Chemistry and a former research scientist in the pharmaceutical industry, has been awarded a $2.5 million, five-year grant from the Defense Threat Reduction Agency (DTRA) to help develop inhibitors of the botulinum toxin, which causes botulism, a life-threatening illness characterized by paralysis and respiratory failure. Rotella is working with government agencies, pharmaceutical companies and other scientists to help the United States combat this serious threat in the war on bioterrorism.
Montclair, NJ -- Elephantiasis, or lymphatic filariasis, is a parasitic disease infecting more than 120 million people in the tropics. According to the World Health Organization, nearly 40 million of them are disfigured and disabled by the infectious disease. Characterized by elephantine enlarged limbs and thickened skin, lymphatic filariasis is caused by a parasite transmitted to humans by mosquito bites.
Port Murray, NJ – Biocia Inc., a New Jersey-based biotechnology company announced the recent commercialization of their viscoadaptive eye drop innovations in a preservative-free delivery system through key Biocia licensing partners in North America for Ocular Surface Disorder (OSD) such as dry eye disease (DED). Biocia licensing partners include Oasis Medical Inc. in the United States (Oasis Tears® PF) and I-MED Pharma in Canada (i-drop® Pur and i-drop® Pur GEL).
Piscataway, NJ – Rutgers Chemistry Professor Martha Greenblatt, Dismukes and colleagues recently published their findings on the patent-pending technology to store energy. They have documented significant progress confronting one of the main challenges inhibiting widespread utilization of sustainable power: Creating a cost-effective process so it can be used later.
Washington D.C. - In a recent Brookings Institute report, Mark Muro and his colleagues discuss the potential of “advanced industries” and their economic renewal in the United States. Industries that invest heavily in research and development (R&D) and science, technology, education, and math (STEM) workers are considered "Advanced Industries." For New Jersey and the NJ Department of Labor, these industries are typically found in the advance manufacturing, technology and life sciences sectors.
Princeton, NJ - Five innovative projects have been awarded support through Princeton University's Dean for Research innovation funds. According to Catherine Zandonella of the Office of the Dean for Research, this fund is in its second year, the program enables faculty members to pursue bold new ideas. "Three projects in the natural sciences will receive $200,000 each over two years and will explore original, early-stage ideas that could serve as the basis of a larger research initiative. In addition, two collaborations with biomedical engineering and neuroscience companies will receive $100,000 each for the first year; Princeton will match each company's contribution of up to $75,000 in the second year."
Do not miss a single innovative moment and sign up for our newsletter!